As we said at Forum LABO and ELRIGfr event, we are convinced that many (not-so) new technologies can enhance work of biologists. Augmented reality is a great tool to see “things that are not here” 🙂 It’s exactly why we have used it to check and validate our future robotic platform compliance (in our Lille laboratories) before delivery. Thanks to our partner Molecular Devices, we have worked on the platform 3D model to put it into a Microsoft Hololens and finally, in our laboratory ! The process is not so complex, when you work with Hololens specialists like dad ( !

As you can see on the video below, our CEO Nathalie talks with Cédric (from Molecular Devices) about small modifications on the platform. They see together the same 3D model. It is also possible to add a third person from a distant place.

It was only the first step ! Now we are working on the training part of our project and, of course, the possibility to maintain the platform from anywhere in the world ! If you have question, don’t hesitate to talk with our CDO Grégory, as you can see on his profile he is also an AR expert !

NIH Grant has been awarded to Hudson Robotics and Johns Hopkins University for in vivo Studies. Cell imaging on in vivo studies on whole organism as zebrafish is a powerfull tool during drug discovery. Nevertheless, the throughput is really low to be used during preliminary drug discovery. Working on implementation of automated system for which a suitable in vivo assay can be developed in high throughput will save time and money while helping to streamline and speed up the drug discovery research process.

In vivo studies are done using a whole living organism. The HTS system being developed is termed the Automated Reporter Quantification in vivo (ARQiv) system. It is being created to bring high-throughput screening technology into the world of in vivo studies.

Curated from

%d bloggers like this: